期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 146, 期 -, 页码 97-125出版社
ELSEVIER
DOI: 10.1016/j.addr.2018.09.010
关键词
Wound healing; Angiogenesis; Growth factor therapy; Cell-based therapies; Stem cell therapy; Neovascularization; Diabetic ulcers; Chronic wounds; Non-healing wounds
资金
- American Heart Association [17IRG33410888]
- DOD CDMRP [W81XWH-16-1-0580, W81XWH-16-1-0582]
- National Institutes of Health [1R21EB023551-01, 1R21EB024147-01A1, 1R01HL141761-01]
- NSF [DGE-1610403]
The enhancement of wound healing has been a goal of medical practitioners for thousands of years. The development of chronic, non-healing wounds is a persistent medical problem that drives patient morbidity and increases healthcare costs. A key aspect of many non-healing wounds is the reduced presence of vessel growth through the process of angiogenesis. This review surveys the creation of new treatments for healing cutaneous wounds through therapeutic angiogenesis. In particular, we discuss the challenges and advancement that have been made in delivering biologic, pharmaceutical and cell-based therapies as enhancers of wound vascularity and healing. (C) 2018 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据